Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

STAT+: Exemption of rare disease therapies in drug-pricing pilots would wipe out huge savings, analysis finds

Excluding rare disease therapies from a Medicare pilot program to lower drug prices would wipe out much of the savings from retail drugs, according to new research.

STAT+: Exemption of rare disease therapies in drug-pricing pilots would wipe out huge savings, analysis finds

We haven't written up this one. STAT News has the full story — the link below goes straight to it.

Read the original at statnews.com →

More in Health & Medicine

More from Wednesday 5 August →